Tower Research Capital (TRC)’s Stemline Therapeutics, Inc. STML Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-7,115
| Closed | -$74K | – | 4813 |
|
2019
Q3 | $74K | Buy |
7,115
+5,583
| +364% | +$58.1K | 0.01% | 1533 |
|
2019
Q2 | $23K | Buy |
+1,532
| New | +$23K | ﹤0.01% | 2104 |
|
2018
Q4 | – | Sell |
-444
| Closed | -$7K | – | 4639 |
|
2018
Q3 | $7K | Sell |
444
-1,558
| -78% | -$24.6K | ﹤0.01% | 2997 |
|
2018
Q2 | $32K | Buy |
+2,002
| New | +$32K | ﹤0.01% | 2137 |
|
2018
Q1 | – | Sell |
-584
| Closed | -$9K | – | 4209 |
|
2017
Q4 | $9K | Sell |
584
-2,325
| -80% | -$35.8K | ﹤0.01% | 2646 |
|
2017
Q3 | $33K | Buy |
2,909
+2,839
| +4,056% | +$32.2K | ﹤0.01% | 2372 |
|
2017
Q2 | $1K | Sell |
70
-1,681
| -96% | -$24K | ﹤0.01% | 2566 |
|
2017
Q1 | $15K | Buy |
1,751
+1,294
| +283% | +$11.1K | ﹤0.01% | 1509 |
|
2016
Q4 | $5K | Buy |
+457
| New | +$5K | ﹤0.01% | 3099 |
|
2016
Q3 | – | Sell |
-1,015
| Closed | -$7K | – | 4858 |
|
2016
Q2 | $7K | Sell |
1,015
-4,192
| -81% | -$28.9K | ﹤0.01% | 3196 |
|
2016
Q1 | $24K | Buy |
5,207
+2,265
| +77% | +$10.4K | ﹤0.01% | 1233 |
|
2015
Q4 | $19K | Buy |
2,942
+117
| +4% | +$756 | ﹤0.01% | 1373 |
|
2015
Q3 | $25K | Buy |
2,825
+2,165
| +328% | +$19.2K | ﹤0.01% | 1561 |
|
2015
Q2 | $8K | Sell |
660
-743
| -53% | -$9.01K | ﹤0.01% | 2933 |
|
2015
Q1 | $20K | Buy |
1,403
+239
| +21% | +$3.41K | ﹤0.01% | 2263 |
|
2014
Q4 | $20K | Sell |
1,164
-1,584
| -58% | -$27.2K | ﹤0.01% | 1608 |
|
2014
Q3 | $34K | Buy |
2,748
+424
| +18% | +$5.25K | ﹤0.01% | 1871 |
|
2014
Q2 | $34K | Buy |
+2,324
| New | +$34K | ﹤0.01% | 1526 |
|
2014
Q1 | – | Sell |
-1,470
| Closed | -$29K | – | 5206 |
|
2013
Q4 | $29K | Buy |
+1,470
| New | +$29K | ﹤0.01% | 1935 |
|
2013
Q3 | – | Sell |
-470
| Closed | -$12K | – | 4980 |
|
2013
Q2 | $12K | Buy |
+470
| New | +$12K | ﹤0.01% | 2225 |
|